论文著作：
1) Yan H#, Sun J#, Wang K#, Wang H, Wu S, Bao L, He W, Wang D, Zhu A, Zhang T, Gao R, Dong B, Li J, Yang L, Zhong M, Lv Q, Qin F, Zhuang Z, Huang X, Yang X, Li Y*, Che Y*, Jiang J*. Repurposing CFDA-approved drug carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2. Acta Pharm Sin B. 2021. doi: 10.1016/j.apsb.2021.02.024. Epub ahead of print. PMID: 33723501; PMCID: PMC7946546.
2) Cui AL#, Sun WF#, Zhong ZJ, Jin J, Xue ST*, Wu S*, Li YH, Li ZR: Synthesis and Bioactivity of N-(4-Chlorophenyl)-4-Methoxy-3-(Methylamino) Benzamide as a Potential Anti-HBV Agent. Drug Des Devel Ther. 2020, 14:3723-3729.
3) Li X#, Wu S#, Du Y, Yang L, Li Y*, Hong B*. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model. Int J Antimicrob Agents. 2020, 56(1):106000.
4) Luo M, Wu S, Kalkeri R, Ptak RG, Zhou T, Van Mellaert L, Wang C, Dumbre SG, Block T, Groaz E, De Jonghe S, Li Y, Herdewijn P. Scalable Synthesis, In Vitro cccDNA Reduction, and In Vivo Antihepatitis B Virus Activity of a Phosphonomethoxydeoxythreosyl Adenine Prodrug. J Med Chem. 2020,63 (22), 13851-13860.
5) Lv K#, Wu S#, Li W, Geng Y, Wu M, Zhou J, Li Y*, Gao Q, Liu M*. Design, synthesis and anti-HBV activity of NVR3-778 derivatives. Bioorg Chem, 2019, 14:103363.
6) Wang A#, Wu S#, Tao Z, Li X, Lv K, Ma C, Li Y*, Li L, Liu M*. Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester Tenofovir Prodrugs. ACS Med Chem Lett, 2019, 10(6):991-995.
7) Wu S, Wang HQ, Guo TT, Li YH. Luteolin inhibits CVB3 replication through inhibiting inflammation. J Asian Nat Prod Res, 2019, 19:1-12.
8) Wu S#, Luo Y#, Viswanathan U, Kulp J, Cheng J, Hu Z, Xu Q, Zhou Y, Gong GZ, Chang J, Li Y*, Guo JT*. CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging. Antiviral Res, 2018, 159:1-12.
9) Zhai X#, Wu S#, Lin L, Wang T, Zhong X, Chen Y, Xu W, Tong L, Wang Y, Zhao W*, Zhong Z*. Stress Granule Formation is One of the Early Antiviral Mechanisms for Host Cells Against Coxsackievirus B Infection. Virol Sin., 2018, 33:314-322.
10) Wu S, Zhao Q, Zhang P, Kulp J, Hu L, Hwang N, Zhang J, Block TM, Xu X, Du Y, Chang J, Guo JT. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly. J Virol, 2017, 91(16).
11) Guo F#, Wu S#, Julander J, Ma J, Zhang X, Kulp J, Cuconati A, Block TM, Du Y, Guo JT, Chang J*. A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein. J Virol, 2016, 90(23):10774-10788.
吴硕
北京市
研究领域：
生物医药
研究方向：
抗病毒药理
所在单位：
中国医学科学院北京协和医学院
